Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales: Harder, Thomas, Koch, Judith, Vygen-Bonnet, Sabine, Külper-Schiek, Wiebe, Pilic, Antonia, Reda, Sarah, Scholz, Stefan, Wichmann, Ole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414955/
https://www.ncbi.nlm.nih.gov/pubmed/34477051
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.35.2100832
_version_ 1783747879470366720
author Harder, Thomas
Koch, Judith
Vygen-Bonnet, Sabine
Külper-Schiek, Wiebe
Pilic, Antonia
Reda, Sarah
Scholz, Stefan
Wichmann, Ole
author_facet Harder, Thomas
Koch, Judith
Vygen-Bonnet, Sabine
Külper-Schiek, Wiebe
Pilic, Antonia
Reda, Sarah
Scholz, Stefan
Wichmann, Ole
author_sort Harder, Thomas
collection PubMed
description
format Online
Article
Text
id pubmed-8414955
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-84149552021-09-14 Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection Harder, Thomas Koch, Judith Vygen-Bonnet, Sabine Külper-Schiek, Wiebe Pilic, Antonia Reda, Sarah Scholz, Stefan Wichmann, Ole Euro Surveill Letter European Centre for Disease Prevention and Control (ECDC) 2021-09-02 /pmc/articles/PMC8414955/ /pubmed/34477051 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.35.2100832 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Letter
Harder, Thomas
Koch, Judith
Vygen-Bonnet, Sabine
Külper-Schiek, Wiebe
Pilic, Antonia
Reda, Sarah
Scholz, Stefan
Wichmann, Ole
Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
title Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
title_full Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
title_fullStr Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
title_full_unstemmed Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
title_short Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
title_sort authors’ response: efficacy and effectiveness of covid-19 vaccines against sars-cov-2 infection: more data on asymptomatic sars-cov-2 infection
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414955/
https://www.ncbi.nlm.nih.gov/pubmed/34477051
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.35.2100832
work_keys_str_mv AT harderthomas authorsresponseefficacyandeffectivenessofcovid19vaccinesagainstsarscov2infectionmoredataonasymptomaticsarscov2infection
AT kochjudith authorsresponseefficacyandeffectivenessofcovid19vaccinesagainstsarscov2infectionmoredataonasymptomaticsarscov2infection
AT vygenbonnetsabine authorsresponseefficacyandeffectivenessofcovid19vaccinesagainstsarscov2infectionmoredataonasymptomaticsarscov2infection
AT kulperschiekwiebe authorsresponseefficacyandeffectivenessofcovid19vaccinesagainstsarscov2infectionmoredataonasymptomaticsarscov2infection
AT pilicantonia authorsresponseefficacyandeffectivenessofcovid19vaccinesagainstsarscov2infectionmoredataonasymptomaticsarscov2infection
AT redasarah authorsresponseefficacyandeffectivenessofcovid19vaccinesagainstsarscov2infectionmoredataonasymptomaticsarscov2infection
AT scholzstefan authorsresponseefficacyandeffectivenessofcovid19vaccinesagainstsarscov2infectionmoredataonasymptomaticsarscov2infection
AT wichmannole authorsresponseefficacyandeffectivenessofcovid19vaccinesagainstsarscov2infectionmoredataonasymptomaticsarscov2infection

Ejemplares similares